Gene Therapy and Therapeutic Editing with Outer or Inner Retina Animal Models

Overview

Journal Vision Res

Specialty Ophthalmology

Date 2023 Sep 17

PMID 37717278

Authors

Wolfgang Baehr

Stephen H Tsang

Affiliations

Soon will be listed here.

References

Gerhardt M, Petersen-Jones S, Michalakis S . CNG channel-related retinitis pigmentosa. Vision Res. 2023; 208:108232. PMC: 10373105. DOI: 10.1016/j.visres.2023.108232. View

Takahashi K, Kwok J, Sato Y, Aguirre G, Miyadera K . Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness. Vision Res. 2023; 209:108260. PMC: 10524691. DOI: 10.1016/j.visres.2023.108260. View

Aweidah H, Xi Z, Sahel J, Byrne L . PRPF31-retinitis pigmentosa: Challenges and opportunities for clinical translation. Vision Res. 2023; 213:108315. PMC: 10872823. DOI: 10.1016/j.visres.2023.108315. View

Diaz-Lezama N, Kajtna J, Wu J, Ayten M, Koch S . Microglial and macroglial dynamics in a model of retinitis pigmentosa. Vision Res. 2023; 210:108268. DOI: 10.1016/j.visres.2023.108268. View

Chirco K, Martinez C, Lamba D . Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases. Vision Res. 2023; 209:108257. PMC: 10524382. DOI: 10.1016/j.visres.2023.108257. View

Cheng Y, Ma C, Jin K, Jin Z . Retinal organoid and gene editing for basic and translational research. Vision Res. 2023; 210:108273. DOI: 10.1016/j.visres.2023.108273. View

Moran A, Fehilly J, Blacque O, Kennedy B . Gene therapy for RAB28: What can we learn from zebrafish?. Vision Res. 2023; 210:108270. DOI: 10.1016/j.visres.2023.108270. View

Jiang L, Zhang H, Dizhoor A, Boye S, Hauswirth W, Frederick J . Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model. Proc Natl Acad Sci U S A. 2011; 108(45):18476-81. PMC: 3215008. DOI: 10.1073/pnas.1112758108. View

Shamshad A, Kang C, Jenny L, Persad-Paisley E, Tsang S . Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases. Vision Res. 2023; 210:108258. PMC: 10526971. DOI: 10.1016/j.visres.2023.108258. View

10.

Kelley R, Wu Z . Utilization of the retinal organoid model to evaluate the feasibility of genetic strategies to ameliorate retinal disease(s). Vision Res. 2023; 210:108269. DOI: 10.1016/j.visres.2023.108269. View

11.

Cideciyan A, Sudharsan R, Dufour V, Massengill M, Iwabe S, Swider M . Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector. Proc Natl Acad Sci U S A. 2018; 115(36):E8547-E8556. PMC: 6130384. DOI: 10.1073/pnas.1805055115. View

12.

Yan A, Du S, Palczewski K . Genome editing, a superior therapy for inherited retinal diseases. Vision Res. 2023; 206:108192. PMC: 10460145. DOI: 10.1016/j.visres.2023.108192. View

13.

Ahmed C, Massengill M, Ildefonso C, Jalligampala A, Zhu P, Li H . Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP). Vision Res. 2023; 206:108189. DOI: 10.1016/j.visres.2023.108189. View

14.

Bigini F, Lee S, Sun Y, Sun Y, Mahajan V . Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases. Vision Res. 2023; 213:108317. PMC: 10685911. DOI: 10.1016/j.visres.2023.108317. View

15.

Cideciyan A, Jacobson S, Sumaroka A, Swider M, Krishnan A, Sheplock R . Photoreceptor function and structure in retinal degenerations caused by biallelic BEST1 mutations. Vision Res. 2022; 203:108157. PMC: 9825664. DOI: 10.1016/j.visres.2022.108157. View

16.

Sechrest E, Chmelik K, Tan W, Deng W . Blue cone monochromacy and gene therapy. Vision Res. 2023; 208:108221. PMC: 10182257. DOI: 10.1016/j.visres.2023.108221. View

17.

Gilmore W, Hultgren N, Chadha A, Barocio S, Zhang J, Kutsyr O . Expression of two major isoforms of MYO7A in the retina: Considerations for gene therapy of Usher syndrome type 1B. Vision Res. 2023; 212:108311. PMC: 10984346. DOI: 10.1016/j.visres.2023.108311. View

18.

Starr C, Chen B . Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma. Vision Res. 2023; 206:108196. PMC: 10085843. DOI: 10.1016/j.visres.2023.108196. View